Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia

Virology Journal

Volumn 3, Issue , 2006, Pages

  Mendy, Maimuna E ^a   Kaye, Steve ^a,b   Van Der Sande, Marianne ^a,c   Rayco Solon, Pura ^a,d   Waight, Pauline A ^a,e   Shipton, Deborah ^a   Awi, Dorka ^a   Snell, Paul ^a   Whittle, Hilton ^a   McConkey, Samuel J ^a,f  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d Nutrition Center of the Philippines   (Philippines)

^e National Protection Agency   (United Kingdom)

^f ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; GAMBIA; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROLOGY; THERMAL EXPOSURE; VIRUS CARRIER; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIVIRAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, VIRAL; GAMBIA; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; LAMIVUDINE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 33745440568     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-23     Document Type: Article

References (24)

1. Lee WM: Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
2. Whittle HC, Inskip H, Bradley AK, McLaughlan K, Shenton F, Lamb W, Eccles J, Baker BA, Hall AJ: The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis 1990, 161:1112-1115.
3. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC: Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999, 17:2946-2950.
4. Bah E, Parkin DM, Hall AJ, Jack AD, Whittle H: Cancer in the Gambia: 1988-97. Br J Cancer 2001, 84:1207-1214.
5. Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW: Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1997, 26:1338-1342.
6. Baker BL, Di Bisceglie AM, Kaneko S, Miller R, Feinstone SM, Waggoner JG, Hoofnagle JH: Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: clinical significance and correlation with serological and biochemical markers. Hepatology 1991, 13:632-636.
7. Krogsgaard K, Kryger P, Aldershvile J, Andersson P, Brechot C: Hepatitis B virus DNA in serum from patients with acute hepatitis B. Hepatology 1985, 5:10-13.
8. Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, Pascual C: The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996, 24:680-685.
9. Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, Verme G, Bonino F: Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989, 10:198-202.
10. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HCJ, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 1990, 323:295-301.
11. Kuhns MC, McNamara AL, Perrillo RP, Cabal CM, Campbel CR: Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol 1989, 27:274-281.
12. Zarski JP, Kuhns M, Berck L, Degos F, Schalm SW, Tiollais P, Brechot C: Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy. Res Virol 1989, 140:283-291.
13. Mendy ME, Fortuin M, Hall AJ, Jack AD, Whittle HC: Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage. Br J Biomed Sci 1999, 56:34-38.
14. Hendricks DA, Stowe BJ, Hoo BS, Kolberg J, Irvine BD, Neuwald PD, Urdea MS, Perrillo RP: Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995, 104:537-546.
15. Gerken G, Gomes J, Lampertico P, Colombo M, Rothaar T, Trippler M, Colucci G: Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 1998, 74:155-165.
16. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS, Chen PJ: Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004, 41:659-666.
17. Kohmoto M, Enomoto M, Yano Y, Otani S, Minamitani S, Tamori A, Habu D, Takeda T, Shiomi S, Seki S, Arakawa T, Nishiguchi S: Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays. Hepatol Res 2003, 26:125-133.
18. Garson JA, Grant PR, Ayliffe U, Ferns RB, Tedder RS: Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods 2005, 126:207-213.
19. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM: High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2005, 35:14-20.
20. Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Niesters HG, Zondervan P, Hansen B, Schalm SW: Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 2005, 365:123-129.
21. Barbaro G, Zechini F, Pellicelli AM, Francavilla R, Scotto G, Bacca D, Bruno M, Babudieri S, Annese M, Matarazzo F, Di Stefano G, Barbarini G: Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. J Hepatol 2001, 35:406-411.
22. Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2001, 34:1225-1241.
23. Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW: Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol 1997, 26:1393-1395.
24. Abdel-Fattah S, el-Kholy MS, Abdel-Fattah SM, el-Shimi S, el-Rasad MM, Mikhail TH, Wassef E: Delta virus and hepatitis B surface antigen in chronic liver diseases. J Egypt Public Health Assoc 1991, 66:427-439.